ONCT
Oncternal Therapeutics, Inc. Common Stock
ONCT
ONCT
Delisted
ONCT was delisted on the 2nd of December, 2024.
54 hedge funds and large institutions have $7.86M invested in Oncternal Therapeutics, Inc. Common Stock in 2023 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 10 increasing their positions, 12 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
54
Holders Change
-4
Holders Change %
-6.9%
% of All Funds
0.86%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
10
Reduced
12
Closed
10
Calls
$7K
Puts
–
Net Calls
+$7K
Net Calls Change
-$20K
Top Buyers
Top Sellers
1 |
BlackRock
New York
|
$715K |
2 |
Two Sigma Investments
New York
|
$64K |
3 |
Two Sigma Advisers
New York
|
$102K |
4 |
TSS
Two Sigma Securities
New York
|
$0 |
5 |
Acadian Asset Management
Boston,
Massachusetts
|
$128K |